FDA Inspection 1195894 — LifeStream Blood Bank
The FDA completed an inspection of LifeStream Blood Bank on Jan 13, 2023 in San Bernardino, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 13, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- San Bernardino, CA (United States)